Utah Medical Products, Inc. (NASDAQ:UTMD) Shares Acquired by Marshall Wace LLP

Marshall Wace LLP grew its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 145.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 11,850 shares of the medical instruments supplier's stock after acquiring an additional 7,019 shares during the quarter. Marshall Wace LLP owned about 0.35% of Utah Medical Products worth $728,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Bard Associates Inc. raised its holdings in shares of Utah Medical Products by 1.3% during the 4th quarter. Bard Associates Inc. now owns 20,030 shares of the medical instruments supplier's stock valued at $1,237,000 after buying an additional 249 shares during the period. Wells Fargo & Company MN grew its holdings in Utah Medical Products by 24.9% during the 4th quarter. Wells Fargo & Company MN now owns 1,927 shares of the medical instruments supplier's stock valued at $118,000 after purchasing an additional 384 shares in the last quarter. Golden State Wealth Management LLC purchased a new stake in Utah Medical Products during the 4th quarter worth $31,000. Bessemer Group Inc. acquired a new stake in shares of Utah Medical Products during the fourth quarter valued at about $31,000. Finally, American Century Companies Inc. increased its position in shares of Utah Medical Products by 8.6% during the fourth quarter. American Century Companies Inc. now owns 8,135 shares of the medical instruments supplier's stock worth $500,000 after acquiring an additional 643 shares during the last quarter. 69.60% of the stock is currently owned by hedge funds and other institutional investors.

Utah Medical Products Price Performance

UTMD traded up $0.40 on Wednesday, reaching $53.93. The company's stock had a trading volume of 15,623 shares, compared to its average volume of 20,076. Utah Medical Products, Inc. has a 1 year low of $51.26 and a 1 year high of $77.33. The business's 50 day moving average is $55.15 and its 200 day moving average is $60.21. The stock has a market cap of $177.00 million, a price-to-earnings ratio of 13.65 and a beta of 0.30.

Utah Medical Products (NASDAQ:UTMD - Get Free Report) last released its quarterly earnings results on Tuesday, April 29th. The medical instruments supplier reported $0.92 earnings per share for the quarter. Utah Medical Products had a net margin of 33.92% and a return on equity of 11.07%. The business had revenue of $9.71 million during the quarter.

Utah Medical Products Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, July 3rd. Stockholders of record on Monday, June 16th will be given a dividend of $0.305 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $1.22 annualized dividend and a dividend yield of 2.26%. Utah Medical Products's payout ratio is 32.28%.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.